VCM
ABBV icon

Vision Capital Management’s AbbVie ABBV Stock Holding History

Vision Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$427K Hold
1,965
– – 0.05% 112
2025
Q4 		$449K Hold
1,965
– – 0.05% 107
2025
Q3 		$455K Sell
1,965
-149
-7% -$30.3K 0.06% 104
2025
Q2 		$392K Buy
2,114
+627
+42% +$117K 0.05% 107
2025
Q1 		$312K Sell
1,487
-627
-30% -$122K 0.04% 112
2024
Q4 		$376K Hold
2,114
– – 0.06% 104
2024
Q3 		$417K Buy
+2,114
New +$395K 0.06% 101
2019
Q1 		– Sell
-48,863
Closed -$4.5M – 81
2018
Q4 		$4.5M Buy
48,863
+503
+1% +$44.2K 1.42% 23
2018
Q3 		$4.57M Sell
48,360
-230
-0.5% -$21.8K 1.24% 30
2018
Q2 		$4.5M Sell
48,590
-32
-0.1% -$3.13K 1.31% 26
2018
Q1 		$4.6M Sell
48,622
-1,832
-4% -$201K 1.36% 24
2017
Q4 		$4.88M Sell
50,454
-886
-2% -$83.5K 1.42% 22
2017
Q3 		$4.56M Sell
51,340
-1,218
-2% -$92.7K 1.45% 23
2017
Q2 		$3.81M Sell
52,558
-12,463
-19% -$838K 1.31% 29
2017
Q1 		$4.24M Sell
65,021
-3,539
-5% -$222K 1.52% 21
2016
Q4 		$4.29M Sell
68,560
-575
-0.8% -$35.1K 1.68% 23
2016
Q3 		$4.36M Buy
69,135
+1,842
+3% +$119K 1.83% 18
2016
Q2 		$4.17M Sell
67,293
-67,136
-50% -$4.09M 1.76% 19
2016
Q1 		$7.68M Buy
134,429
+3,750
+3% +$209K 1.87% 22
2015
Q4 		$7.74M Sell
130,679
-87,722
-40% -$5.05M 1.77% 28
2015
Q3 		$11.9M Sell
218,401
-5,374
-2% -$350K 2.66% 13
2015
Q2 		$15M Sell
223,775
-61,438
-22% -$4.01M 2.8% 8
2015
Q1 		$16.7M Buy
285,213
+110,553
+63% +$6.68M 2.5% 21
2014
Q4 		$11.4M Buy
+174,660
New +$11M 1.32% 40

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vision Capital Management's ABBV Position: Q1 2026 in Review

Vision Capital Management held its AbbVie (ABBV) position steady in Q1 2026 at 1,965 shares worth $427K. The position accounts for 0.05% of the portfolio, ranked #112.

Vision Capital Management first reported a position in ABBV in Q4 2014 and has held it in 24 quarters since. The position peaked at $16.7M in Q1 2015. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Vision Capital Management held 1,965 shares of AbbVie worth $427K as of Q1 2026.
  • Vision Capital Management left its AbbVie share count unchanged in Q1 2026.
  • AbbVie made up 0.05% of Vision Capital Management's portfolio in Q1 2026, its #112 holding.
  • Vision Capital Management first reported a position in AbbVie in Q4 2014 and has held it in 24 quarters since.
  • Vision Capital Management's AbbVie position peaked at $16.7M in Q1 2015.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Vision Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.